The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Warren Howland Shaw since year 2005.
The trader's CIK number is 1291769.
At the time of this reporting, Warren Howland Shaw is the Director of
Critical Therapeutics Inc
(stock ticker symbol CRTX).
Stock purchases, sales, and option exercises reported by Warren Howland Shaw since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-04-06
CRTX
Critical Therapeutics Inc
Option Exercise
21,356
1.05
22,423
2006-03-28
CRTX
Critical Therapeutics Inc
Sale
8,000
5.03
40,211
2006-03-14
CRTX
Critical Therapeutics Inc
Sale
8,000
5.57
44,544
2006-02-28
CRTX
Critical Therapeutics Inc
Sale
8,000
5.42
43,368
2006-01-24
CRTX
Critical Therapeutics Inc
Sale
8,000
6.30
50,440
2006-01-10
CRTX
Critical Therapeutics Inc
Sale
8,000
6.73
53,840
2005-12-27
CRTX
Critical Therapeutics Inc
Sale
8,000
6.71
53,664
2005-12-13
CRTX
Critical Therapeutics Inc
Sale
8,000
6.74
53,960
2005-11-22
CRTX
Critical Therapeutics Inc
Sale
8,000
6.53
52,240
2005-11-08
CRTX
Critical Therapeutics Inc
Sale
8,000
7.55
60,384
2005-10-25
CRTX
Critical Therapeutics Inc
Sale
8,000
8.71
69,712
2005-10-11
CRTX
Critical Therapeutics Inc
Sale
8,000
8.51
68,064
2005-10-11
CRTX
Critical Therapeutics Inc
Sale
8,000
8.51
68,064
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Warren Howland Shaw
(Director of Critical Therapeutics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
